Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis
Top Cited Papers
Open Access
- 23 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 113 (11), 1465-1475
- https://doi.org/10.1093/jnci/djab023
Abstract
Obesity at breast cancer (BC) diagnosis has been associated with poor outcome, although the magnitude of effect in different BC subtypes is uncertain. We report on the association of obesity/overweight at diagnosis of non-metastatic BC with disease-free (DFS) and overall survival (OS) in the following defined subtypes: hormone receptor positive/HER2 negative (HR+HER2-), HER2 positive (HER2+), and triple negative (TNBC). We searched MEDLINE, EMBASE and COCHRANE databases until January 1, 2019. Study eligibility were performed independently by two authors. Studies reporting hazard ratios (HR) of OS and/or DFS for obesity/overweight in BC subtypes were included. Pooled HR were computed and weighted using generic inverse variance and random effects models. 27 studies were included. Obese, compared to non-obese, women, had worse DFS in all subtypes: the hazard ratios were 1.26 (95% confidence interval [CI] = 1.13 to 1.41, P < .001) for HR+HER2-BC, 1.16 (95%CI = 1.06 to 1.26, P < .001) for HER2+ BC, and 1.17 (95%CI = 1.06 to 1.29, P = .001) for TNBC. OS was also worse in obese vs non-obese women (HR+HER2-BC HR = 1.39, 95%CI = 1.20 to 1.62, P < .001; HER2+BC HR = 1.18, 95%CI = 1.05 to 1.33, P = .006 and TNBC HR = 1.32, 95%CI = 1.13 to 1.53, P < .001). As opposed to obesity, overweight was not associated with either DFS or OS in HER2+BC (HR = 1.02, 95%CI = 0.81 to 1.28, P = .85; and HR = 0.96, 95%CI = 0.76 to 1.21, P = .99, respectively) or TNBC (HR = 1.04, 95%CI = 0.93 to 1.18, P = .49; and HR = 1.08, 95%CI = 0.81 to 1.44, P = .17), respectively. In HR+HER2-BC, being overweight was associated with worse OS (HR = 1.14, 95%CI = 1.07 to 1.22, P < .001). Obesity was associated with modestly worse DFS and OS in all BC subtypes.Funding Information
- The Breast Cancer Research Foundation
- Hold’em For Life Charities
This publication has 42 references indexed in Scilit:
- Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisBreast Cancer Research, 2013
- Impact of Body Mass Index on Survival Outcome Among Women With Early Stage Triple-Negative Breast CancerClinical Breast Cancer, 2012
- Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancerCancer, 2012
- Cognitive-behavioural interventions for children who have been sexually abusedEmergencias, 2012
- Impact of body mass index on clinical outcomes in triple‐negative breast cancerCancer, 2011
- Triple-negative breast cancer in Hispanic patientsCancer, 2011
- Molecular Stratification of Triple-Negative Breast CancersThe Oncologist, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010